Weight Loss
Medical weight loss at Kure Health addresses the metabolic root causes of weight gain — insulin resistance, thyroid dysfunction, cortisol dysregulation, estrogen dominance, gut microbiome imbalance, and chronic inflammation — rather than relying solely on caloric restriction or GLP-1 medications. Signal-Based Medicine™ uses the KureBioMap™ to identify exactly which metabolic signals are disrupted, then builds personalized protocols that may include GLP-1 medications as a bridge while the underlying dysfunction is corrected for sustainable, long-term results.
You've Tried Everything. Your Metabolism Hasn't Been Asked Why.
Diets fail. Willpower fails. Even Ozempic stops working when you stop taking it — because the underlying metabolic dysfunction is still there. Weight loss resistance isn't a discipline problem. It's a signal problem: insulin that won't respond, thyroid that won't convert, cortisol that won't calm down, estrogen that won't clear. We find which signals are stuck and restore them.
Why Diets and Willpower Are Not the Problem
Every Los Angeles member who walks into Kure Health for weight loss has already tried. They have counted calories, eliminated food groups, hired trainers, joined programs, and demonstrated more discipline than most people will ever summon. The weight came off temporarily and returned, or it never came off at all. The medical system's response is to suggest they try harder, eat less, or consider bariatric surgery.
The problem was never effort. The problem is that weight loss resistance is a metabolic signal dysfunction, and no amount of caloric restriction can override a body whose signaling systems are actively promoting fat storage. Insulin resistance tells your body to store every available calorie as fat regardless of intake. Thyroid conversion failure slows your metabolic rate below what any diet can overcome. Cortisol dysregulation redistributes weight to the abdomen through mechanisms that diet and exercise cannot influence. Leptin resistance prevents your brain from recognizing that you have adequate fat stores.
These are not theories. They are measurable biochemical states that standard Los Angeles County weight loss programs never test for. A Los Angeles member with a fasting insulin of 18 mIU/L has insulin resistance that will defeat every caloric deficit. A member with a Free T3 of 2.2 pg/mL has thyroid conversion failure that is slowing their metabolism by 20 to 30 percent. A member with a flattened cortisol curve is storing abdominal fat through a hormonal mechanism that no exercise program can override.
Signal-Based Medicine identifies which specific metabolic signals are blocking your weight loss and corrects them. The weight loss follows because the obstacle has been removed.
The 7 Metabolic Signals Behind Weight Loss Resistance
KureBioMap™ evaluates seven metabolic signal pathways that drive weight loss resistance in Los Angeles members. Any single pathway can block weight loss. Most members have two to four operating simultaneously, which explains why addressing only one, as most programs do, produces incomplete or temporary results.
Signal one is insulin resistance. Elevated fasting insulin with a HOMA-IR above 2.0 indicates that cells are resistant to insulin signaling, forcing the body to produce more insulin. Insulin is the primary fat storage hormone. Elevated insulin locks fat in adipose tissue and prevents its mobilization for energy regardless of caloric deficit. Signal two is thyroid conversion failure, where T4 is produced normally but conversion to active T3 is impaired by inflammation, nutrient deficiency, or stress, reducing metabolic rate by 20 to 30 percent.
Signal three is cortisol dysregulation. Chronic stress produces either elevated or flattened cortisol patterns, both of which promote visceral fat accumulation and muscle catabolism. Signal four is leptin resistance, where chronically elevated leptin from excess adipose tissue desensitizes hypothalamic receptors, preventing the brain from recognizing satiety signals. Signal five is gut microbiome imbalance, where an elevated Firmicutes-to-Bacteroidetes ratio increases caloric extraction from food by up to 150 calories daily.
Signal six is estrogen dominance, where elevated estrogen relative to progesterone promotes fat storage in hips, thighs, and abdomen in both men and women. Signal seven is methylation dysfunction from MTHFR or related genetic variants, impairing the detoxification and metabolic pathways required for efficient fat metabolism. KureBioMap™ identifies which of these seven signals are active in each Los Angeles member.
GLP-1 Medications: Bridge, Not Destination
GLP-1 receptor agonists including semaglutide and tirzepatide have transformed the weight loss landscape. They work. Members lose 15 to 20 percent of body weight on average. For Los Angeles members struggling with significant weight loss resistance, these medications provide something that diet and exercise alone cannot: pharmacological intervention in the appetite and insulin signaling pathways.
The problem is what happens next. Research consistently shows that approximately two-thirds of weight lost on GLP-1 medications returns within 12 months of discontinuation. The medications suppress appetite and improve insulin sensitivity while active. They do not correct the underlying metabolic signal dysfunctions that caused the weight gain. When the medication stops, the uncorrected signals resume their effect and the weight returns.
Kure Health prescribes GLP-1 medications when clinically appropriate, but never as a standalone treatment. Every Los Angeles weight loss member receives a comprehensive KureBioMap™ Assessment before medication is considered. The assessment identifies which of the seven metabolic signals are driving the weight gain. A treatment protocol is built to correct these root causes during the medication period, so that when the GLP-1 medication is tapered and discontinued, the metabolic environment has been repaired.
This is the difference between weight loss and weight loss that lasts. The medication provides the momentum. Signal-Based Medicine provides the correction. The combination produces sustainable results because the body's signaling systems have been restored to function, not just temporarily overridden by pharmacology. Los Angeles members can access this comprehensive approach by calling (888) 949-KURE.
Preserving Muscle While Losing Fat
One of the most significant concerns with rapid weight loss, whether from GLP-1 medications, aggressive caloric restriction, or bariatric surgery, is the loss of lean muscle mass alongside fat. Research on semaglutide shows that up to 40 percent of weight lost can be lean tissue rather than fat. For Los Angeles members over 40, this muscle loss has cascading consequences: reduced metabolic rate making future weight regain more likely, decreased functional strength, accelerated biological aging, and increased fall risk in older adults.
Signal-Based Medicine addresses this directly. KureBioMap™ identifies hormonal factors that influence body composition: testosterone levels in men and women, growth hormone and IGF-1 status, cortisol patterns that promote muscle catabolism, and insulin sensitivity that affects nutrient partitioning between muscle and fat storage. Optimizing these hormonal signals during weight loss shifts the ratio of fat loss to muscle loss dramatically.
The treatment protocol includes targeted interventions for muscle preservation: protein optimization based on lean body mass calculation, resistance training guidance calibrated to hormonal status, amino acid therapy when indicated, peptide protocols including CJC/Ipamorelin for growth hormone support, and testosterone optimization when deficiency is documented. For members on GLP-1 medications, these interventions run concurrently to ensure that the weight being lost is predominantly fat.
Body composition is monitored through the treatment period, tracking fat mass, lean mass, and visceral fat independently rather than relying on scale weight alone. For Los Angeles members, the goal is not just a lower number on the scale. It is a fundamentally improved body composition with preserved metabolic capacity.
Medical Weight Loss for Los Angeles Residents
Kure Health provides comprehensive medical weight loss for Los Angeles residents through Signal-Based Medicine, addressing the root metabolic causes of weight gain rather than offering another diet plan or standalone medication prescription. The approach is designed for members who have tried conventional weight loss methods and experienced either failure or temporary success followed by regain.
The process begins with the KureBioMap™ Assessment, which identifies your specific combination of metabolic signal dysfunctions from the seven pathways that drive weight loss resistance. This is not a generic metabolic panel. It is a 14,000+ data point evaluation that reveals why your body is resisting weight loss at the biochemical level. The treatment protocol is built entirely from your results.
Treatment may include GLP-1 medication as a bridge when clinically indicated, hormonal optimization to restore metabolic rate and body composition signaling, insulin sensitization through targeted supplementation and dietary modification, gut microbiome restoration to correct bacterial ratios affecting caloric extraction, cortisol regulation through adrenal support protocols, and IV nutrient therapy for documented deficiencies affecting metabolism.
Los Angeles residents can access the full weight loss program in person at our Downtown Los Angeles center or through our comprehensive telehealth program with labs drawn at partner facilities throughout Los Angeles County. Follow-up assessments track not just weight but body composition, metabolic markers, hormonal optimization, and inflammatory status to ensure that root causes are being corrected alongside the weight loss.
Stop starting another diet that does not address why you gained the weight. Call (888) 949-KURE to schedule your KureBioMap™ Assessment.
